OPWM
GILD icon

Oak Point Wealth Management’s Gilead Sciences GILD Stock Holding History

Oak Point Wealth Management’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		$5K Hold
65
– – 0.01% 174
2017
Q4 		$5K Buy
+65
New +$4.94K ﹤0.01% 174

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Parnassus Investments
Parnassus Investments San Francisco, California $37.4B AUM 35.42% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Oak Point Wealth Management's GILD Position: Q1 2018 in Review

Oak Point Wealth Management held its Gilead Sciences (GILD) position steady in Q1 2018 at 65 shares worth $5K. The position accounts for 0.01% of the portfolio, ranked #174.

Oak Point Wealth Management first reported a position in GILD in Q4 2017 and has held it in 2 quarters since. 1,564 funds tracked by Wall St. Rank hold GILD as of Q1 2018.

  • Oak Point Wealth Management held 65 shares of Gilead Sciences worth $5K as of Q1 2018.
  • Oak Point Wealth Management left its Gilead Sciences share count unchanged in Q1 2018.
  • Gilead Sciences made up 0.01% of Oak Point Wealth Management's portfolio in Q1 2018, its #174 holding.
  • Oak Point Wealth Management first reported a position in Gilead Sciences in Q4 2017 and has held it in 2 quarters since.
  • 1,564 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2018.

Based on Oak Point Wealth Management's 13F filing for Q1 2018, filed 30 Apr 2018.